Synopsis
Synopsis
0
VMF
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2 Propylpentanoic Acid
2. 2-propylpentanoic Acid
3. Calcium Valproate
4. Convulsofin
5. Depakene
6. Depakine
7. Depakote
8. Dipropyl Acetate
9. Divalproex
10. Ergenyl
11. Magnesium Valproate
12. Propylisopropylacetic Acid
13. Semisodium Valproate
14. Sodium Valproate
15. Valproate
16. Valproate Calcium
17. Valproate Sodium
18. Valproic Acid
19. Valproic Acid, Sodium Salt (2:1)
20. Vupral
1. 76584-70-8
2. Valproate Semisodium
3. Epival
4. Depakote
5. Sodium Divalproate
6. Semisodium Valproate
7. Sprinkle
8. Abbott 50711
9. Divalproex
10. Valdisoval
11. Valproato Semisodico
12. Delepsine
13. Valcote
14. Valparin
15. Epilex
16. Valproate Semisodique
17. Sodium Hydrogen Divalproate
18. Valproatum Seminatricum
19. Sodium Hydrogen Bis(2-propylpentanoate)
20. Pentanoic Acid, 2-propyl-, Sodium Salt (2:1)
21. Abbott-50711
22. Sodium Hydrogen Bis(2-propylvalerate)
23. Divalproex Sodium [usan:usp]
24. Divalproex (sodium)
25. Sodium;2-propylpentanoate;2-propylpentanoic Acid
26. Valproate Semisodium (inn)
27. Depakote Er
28. Chebi:4667
29. Divalproate
30. Valproic Acid (semisodium Salt)
31. Depakote Cp
32. Valproate Semisodium [inn]
33. Valproate Semisodique [french]
34. Valproato Semisodico [spanish]
35. Valproatum Seminatricum [latin]
36. Valproic Acid Semisodium Salt
37. Depakote (tn)
38. Natrium Hydrogen Bis(2-propylvalerat)
39. Valproic Acid Semisodium Salt (2:1)
40. 644vl95ao6
41. Valproic Acid Sodium Salt (2:1)
42. Divalproex Sodium (usp)
43. Unii-644vl95ao6
44. Sodium Divalproex
45. Sodium Hydrogen Bis(2-propylvalerate), Oligomer
46. Sodium; 2-propylpentanoate; 2-propylpentanoic Acid
47. Schembl40996
48. Chembl2105613
49. Sodium;hydron;2-propylpentanoate
50. Dtxsid70227388
51. Hms3651c17
52. Hms3884o06
53. Bcp12800
54. S1703
55. Sodiumhydrogenbis(2-propylpentanoate)
56. Akos015895200
57. Ccg-267581
58. As-17254
59. Db-056089
60. Ft-0625375
61. Sw219169-1
62. C76453
63. D00304
64. Ab01568255_01
65. A838751
66. Sodium 2-propylpentanoate--2-propylpentanoic Acid (1:1)
Molecular Weight | 310.40 g/mol |
---|---|
Molecular Formula | C16H31NaO4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 10 |
Exact Mass | 310.21200375 g/mol |
Monoisotopic Mass | 310.21200375 g/mol |
Topological Polar Surface Area | 77.4 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 192 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 6 | |
---|---|
Drug Name | Depakote |
Drug Label | Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is d... |
Active Ingredient | Divalproex sodium |
Dosage Form | Capsule, delayed rel pellets; Tablet, delayed release |
Route | Oral |
Strength | eq 125mg valproic acid; eq 500mg valproic acid; eq 250mg valproic acid |
Market Status | Prescription |
Company | Abbvie |
2 of 6 | |
---|---|
Drug Name | Depakote er |
Drug Label | Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is d... |
Active Ingredient | Divalproex sodium |
Dosage Form | Tablet, extended release |
Route | oral; Oral |
Strength | 250mg; eq 500mg valproic acid; eq 250mg valproic acid; 500mg |
Market Status | Prescription |
Company | Abbott; Abbvie |
3 of 6 | |
---|---|
Drug Name | Divalproex sodium |
Drug Label | Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship. Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium has the following structure:Di... |
Active Ingredient | Divalproex sodium |
Dosage Form | Tablet, extended release; Capsule, delayed rel pellets; Tablet, delayed release |
Route | Oral |
Strength | eq 125mg valproic acid; eq 500mg valproic acid; eq 250mg valproic acid |
Market Status | Prescription |
Company | Anchen Pharms; Wockhardt; Upsher Smith; Nu Pharm; Actavis Labs Fl; Teva; Vintage; Aurobindo Pharma; Sun Pharm Inds; Reddys; Lupin; Zydus Pharms Usa; Dr Reddys Labs; Sandoz; Orchid Hlthcare; Mylan; Unichem Labs; Impax Labs |
4 of 6 | |
---|---|
Drug Name | Depakote |
Drug Label | Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is d... |
Active Ingredient | Divalproex sodium |
Dosage Form | Capsule, delayed rel pellets; Tablet, delayed release |
Route | Oral |
Strength | eq 125mg valproic acid; eq 500mg valproic acid; eq 250mg valproic acid |
Market Status | Prescription |
Company | Abbvie |
5 of 6 | |
---|---|
Drug Name | Depakote er |
Drug Label | Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is d... |
Active Ingredient | Divalproex sodium |
Dosage Form | Tablet, extended release |
Route | oral; Oral |
Strength | 250mg; eq 500mg valproic acid; eq 250mg valproic acid; 500mg |
Market Status | Prescription |
Company | Abbott; Abbvie |
6 of 6 | |
---|---|
Drug Name | Divalproex sodium |
Drug Label | Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship. Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium has the following structure:Di... |
Active Ingredient | Divalproex sodium |
Dosage Form | Tablet, extended release; Capsule, delayed rel pellets; Tablet, delayed release |
Route | Oral |
Strength | eq 125mg valproic acid; eq 500mg valproic acid; eq 250mg valproic acid |
Market Status | Prescription |
Company | Anchen Pharms; Wockhardt; Upsher Smith; Nu Pharm; Actavis Labs Fl; Teva; Vintage; Aurobindo Pharma; Sun Pharm Inds; Reddys; Lupin; Zydus Pharms Usa; Dr Reddys Labs; Sandoz; Orchid Hlthcare; Mylan; Unichem Labs; Impax Labs |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
Antimanic Agents
Agents that are used to treat bipolar disorders or mania associated with other affective disorders. (See all compounds classified as Antimanic Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
GABA Agents
Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as GABA Agents.)
Registrant Name : Sanofi-Aventis Korea Co., Ltd.
Registration Date : 2021-03-10
Registration Number : 20210310-209-J-870
Manufacturer Name : Sanofi Winthrop Industrie
Manufacturer Address : Chem Pole 64, Avenue Du Lac, Mourenx, 64150, France
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : CEP 2004-226 - Rev 05
Issue Date : 2024-02-02
Type : Chemical
Substance Number : 1378
Status : Valid
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5678
Submission : 1985-01-18
Status : Active
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 49169-1028
Start Marketing Date : 2010-07-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-09-13
Pay. Date : 2015-09-08
DMF Number : 16558
Submission : 2003-04-28
Status : Active
Type : II
Certificate Number : CEP 2003-108 - Rev 06
Issue Date : 2025-04-16
Type : Chemical
Substance Number : 1378
Status : Valid
Registration Number : 220MF10111
Registrant's Address : No. 61, Ln. 309, Haihu N. Rd. , Luzhu Dist. , Taoyuan City 33856, Taiwan
Initial Date of Registration : 2008-04-21
Latest Date of Registration :
NDC Package Code : 68108-0234
Start Marketing Date : 2012-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Base Farm Co., Ltd.
Registration Date : 2022-05-17
Registration Number : 20201125-209-J-769(2)
Manufacturer Name : SCI Pharmtech, Inc
Manufacturer Address : No.61, Ln.309, Haihu N. Rd., Luzhu Dist. Taoyuan City 33856, Taiwan
Available Reg Filing : CA, CN |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14646
Submission : 1999-12-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5678
Submission : 1985-01-18
Status : Active
Type : II
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
GDUFA
DMF Review : Complete
Rev. Date : 2014-12-16
Pay. Date : 2014-11-26
DMF Number : 18285
Submission : 2005-04-08
Status : Active
Type : II
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
GDUFA
DMF Review : Complete
Rev. Date : 2015-09-13
Pay. Date : 2015-09-08
DMF Number : 16558
Submission : 2003-04-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4657
Submission : 1982-09-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3061
Submission : 1977-11-14
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-31
Pay. Date : 2013-09-18
DMF Number : 6428
Submission : 1986-06-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7380
Submission : 1988-03-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4380
Submission : 1981-10-26
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3211
Submission : 1978-05-23
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : CEP 2004-226 - Rev 05
Status : Valid
Issue Date : 2024-02-02
Type : Chemical
Substance Number : 1378
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
Certificate Number : CEP 2003-108 - Rev 06
Status : Valid
Issue Date : 2025-04-16
Type : Chemical
Substance Number : 1378
Certificate Number : R1-CEP 2003-174 - Rev 03
Status : Valid
Issue Date : 2020-02-21
Type : Chemical
Substance Number : 1378
Certificate Number : CEP 2020-374 - Rev 01
Status : Valid
Issue Date : 2024-08-26
Type : Chemical
Substance Number : 1378
Certificate Number : CEP 2015-158 - Rev 02
Status : Valid
Issue Date : 2025-04-16
Type : Chemical
Substance Number : 1378
Certificate Number : R1-CEP 2004-015 - Rev 04
Status : Withdrawn by Holder
Issue Date : 2014-12-04
Type : Chemical
Substance Number : 1378
Certificate Number : R1-CEP 1998-026 - Rev 03
Status : Valid
Issue Date : 2015-08-06
Type : Chemical
Substance Number : 1378
Certificate Number : R1-CEP 2006-310 - Rev 04
Status : Valid
Issue Date : 2020-03-11
Type : Chemical
Substance Number : 1378
Certificate Number : CEP 2014-140 - Rev 02
Status : Valid
Issue Date : 2024-04-02
Type : Chemical
Substance Number : 1378
Certificate Number : R1-CEP 2001-287 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2012-10-02
Type : Chemical
Substance Number : 1378
Date of Issue : 2021-09-17
Valid Till : 2024-07-10
Written Confirmation Number : WC-0428
Address of the Firm : Plot No. 23 E, Survey No. 24P & 25P, AP SEZ Denotified Area, Lalamkoduru (V), Ra...
Date of Issue : 2022-06-06
Valid Till : 2025-07-21
Written Confirmation Number : WC-0044
Address of the Firm : Plot No. A-100, A-100/1, A-100/2 & D-1, M.I.D.C Ind. Area, Shendra, Aurangabad-4...
Date of Issue : 2022-06-06
Valid Till : 2025-07-21
Written Confirmation Number : WC-0044
Address of the Firm : Plot No. A-100, A-100/1, A-100/2 & D-1, M.I.D.C Ind. Area, Shendra, Aurangabad-4...
Date of Issue : 2022-09-30
Valid Till : 2025-08-08
Written Confirmation Number : WC-0066
Address of the Firm : Plot No 1, Hetero Infrastructure SEZ Ltd., N. Narasapuram, Anakapalli -531081, A...
Date of Issue : 2024-02-12
Valid Till : 2027-02-11
Written Confirmation Number : WC-0407
Address of the Firm : Sy. No. 205, 222 to 226, IDA Bonthapally, Bonthapally (Village), Gummadidala (Ma...
Date of Issue : 2022-09-30
Valid Till : 2025-10-09
Written Confirmation Number : WC-0243
Address of the Firm : Sathammai Village, Karunkuzhi Post, Madhuranthagam Taluk, Kancheepuram District,...
Date of Issue : 2022-09-30
Valid Till : 2025-10-09
Written Confirmation Number : WC-0243
Address of the Firm : Sathammai Village, Karunkuzhi Post, Madhuranthagam Taluk, Kancheepuram District,...
Date of Issue : 2022-09-30
Valid Till : 2025-10-09
Written Confirmation Number : WC-0243
Address of the Firm : Sathammai Village, Karunkuzhi Post, Madhuranthagam Taluk, Kancheepuram District,...
Date of Issue : 2022-06-08
Valid Till : 2025-07-25
Written Confirmation Number : WC-0159nA2
Address of the Firm : A-7/A-8, M.I.D.C Industrial Area, Ahmednagar-414111, Maharashtra, India
Date of Issue : 2022-06-08
Valid Till : 2025-07-25
Written Confirmation Number : WC-0159nA2
Address of the Firm : A-7/A-8, M.I.D.C Industrial Area, Ahmednagar-414111, Maharashtra, India
Registrant Name : Sanofi-Aventis Korea Co., Ltd.
Registration Date : 2021-03-10
Registration Number : 20210310-209-J-870
Manufacturer Name : Sanofi Winthrop Industrie
Manufacturer Address : Chem Pole 64, Avenue Du Lac, Mourenx, 64150, France
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
Registrant Name : Base Farm Co., Ltd.
Registration Date : 2022-05-17
Registration Number : 20201125-209-J-769(2)
Manufacturer Name : SCI Pharmtech, Inc
Manufacturer Address : No.61, Ln.309, Haihu N. Rd., Luzhu Dist. Taoyuan City 33856, Taiwan
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2020-11-25
Registration Number : 20201125-209-J-769
Manufacturer Name : SCI Pharmtech, Inc
Manufacturer Address : No.61, Ln.309, Haihu N. Rd., Luzhu Dist. Taoyuan City 33856, Taiwan
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
Registrant Name : Hwanin Pharmaceutical Co., Ltd.
Registration Date : 2021-08-11
Registration Number : 20201125-209-J-769(1)
Manufacturer Name : SCI Pharmtech, Inc
Manufacturer Address : No.61, Ln.309, Haihu N. Rd., Luzhu Dist. Taoyuan City 33856, Taiwan
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2021-05-18
Registration Number : 20210518-211-J-666
Manufacturer Name : SCI Pharmtech, Inc
Manufacturer Address : No.61, Ln.309, Haihu N. Rd., Luzhu Dist. Taoyuan City 33856, Taiwan
Registrant Name : Abbott Korea Ltd.
Registration Date : 2021-06-10
Registration Number : 20210610-209-J-1018
Manufacturer Name : Anjan Drug Private Limited
Manufacturer Address : Plot Nos.: 109, 110, 115 & 116,SIDCO Pharmaceutical Industrial Estate,Old Mamallapura...
Registrant Name : Narsha Farm Co., Ltd.
Registration Date : 2023-01-10
Registration Number : 20230110-209-J-1434
Manufacturer Name : Harman Finochem Limited
Manufacturer Address : A-100, A-100/1, A-100/2 & D-1, MIDC Industrial Area, Shendra, Aurangabad -431 007, Ma...
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2021-06-10
Registration Number : 20210610-209-J-1020
Manufacturer Name : Katwijk Chemie BV
Manufacturer Address : Snijderstraat 6, 2222BA, Katwijk ZH, The Netherlands
Registrant Name : Pami Future Co., Ltd.
Registration Date : 2020-08-13
Registration Number : 20200813-209-J-572
Manufacturer Name : Sun Pharmaceutical Industrie...
Manufacturer Address : A-7/A-8, MIDC Industrial Area, Ahmednagar 414111, Maharashtra State, India
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 68925-0005
Start Marketing Date : 2009-12-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 49169-1028
Start Marketing Date : 2010-07-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
NDC Package Code : 68108-0234
Start Marketing Date : 2012-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 23639-0003
Start Marketing Date : 1982-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0114
Start Marketing Date : 1984-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17349-0011
Start Marketing Date : 2002-12-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17349-0005
Start Marketing Date : 1984-06-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70600-016
Start Marketing Date : 2019-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47621-006
Start Marketing Date : 2021-01-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-2542
Start Marketing Date : 2016-03-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
About the Company : EUROAPI is focused on reinventing active ingredient solutions to meet the needs of customers and patients worldwide sustainably. We are a leading player in APIs with approximately ...
About the Company : We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
About the Company : Chynops Pharma, a company certified with ISO 9001:2015, is situated in Ahmedabad, India. We specialize in exporting, supplying, and trading a wide range of products, including APIs...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
About the Company : SCI Pharmtech Inc. offers APIs, advanced intermediates, and custom products, focusing on quick development and cost-effective production. Our research labs, pilot plants, and produ...
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
About the Company : SCI Pharmtech Inc. offers APIs, advanced intermediates, and custom products, focusing on quick development and cost-effective production. Our research labs, pilot plants, and produ...
About the Company : Venkar Chemicals Pvt. Ltd. is a WHO-GMP, ISO 9001:2008, and ISO 14000:2004 certified company and a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediate...
About the Company : Biesterfeld Spezialchemie GmbH is a part of the Biesterfeld Group. Biesterfeld Spezialchemie GmbH is a pan-European, rapidly growing distributor of products requiring special perfo...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Divalproex sodium is an GABA stimulating, anti-epileptic drug indicated for monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures.
Lead Product(s): Divalproex Sodium
Therapeutic Area: Neurology Brand Name: Depakote Sprinkle-Generic
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 20, 2024
Lead Product(s) : Divalproex Sodium
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Alembic Pharma Gets USFDA Nod for Seizure Treatment Drug
Details : Divalproex sodium is an GABA stimulating, anti-epileptic drug indicated for monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures.
Product Name : Depakote Sprinkle-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 20, 2024
Details:
CS1 is an HDAC inhibitor that works through epigenetic modulation, being developed as a safe, effective and disease modifying treatment for pulmonary arterial hypertension.
Lead Product(s): Divalproex Sodium,Sodium Valproate
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: CS1
Study Phase: Phase IIProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 30, 2024
Lead Product(s) : Divalproex Sodium,Sodium Valproate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Cereno's HDAC Inhibitor Reduces Risks from PAH in Phase 2 Trial
Details : CS1 is an HDAC inhibitor that works through epigenetic modulation, being developed as a safe, effective and disease modifying treatment for pulmonary arterial hypertension.
Product Name : CS1
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 30, 2024
Details:
CS1 is an HDAC (Histone DeACetylase) inhibitor that acts as an epigenetic modulator with anti-thrombotic, anti-inflammatory, anti-fibrotic and pressure-relieving properties, all relevant for PAH.
Lead Product(s): Divalproex Sodium
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: CS1
Study Phase: Phase IProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 17, 2021
Lead Product(s) : Divalproex Sodium
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : CS1 is an HDAC (Histone DeACetylase) inhibitor that acts as an epigenetic modulator with anti-thrombotic, anti-inflammatory, anti-fibrotic and pressure-relieving properties, all relevant for PAH.
Product Name : CS1
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 17, 2021
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Depakin
Dosage Form : Valproic Acid+Sodium Valproate 1.000Mg 30 Joined' Oral Use Rm
Dosage Strength : os grat 30 bust 1,000 mg modified release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Depakin
Dosage Form : Valproic Acid+Sodium Valproate 250Mg 30 Joined' Oral Use Rm
Dosage Strength : os grat 30 bust 250 mg modified release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Depakin Chrono
Dosage Form : Valproic Acid+Sodium Valproate 500Mg 30 Joined' Oral Use Rp
Dosage Strength : 30 CPR 500 mg prolonged release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Acidum valproicum; sodium valproas
Brand Name : Depakine Chrono
Dosage Form : Film-Coated Tablets
Dosage Strength : 300mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Epilim CR 200
Dosage Form : TAB
Dosage Strength : 200mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Epilim Intravenous
Dosage Form : INJ
Dosage Strength : 400mg/4ml
Packaging : 4X1mg/4ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Australia
Brand Name : Epilim Syrup
Dosage Form : oral
Dosage Strength : 200 mg/5 mL
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Australia
Brand Name : Epilim EC
Dosage Form :
Dosage Strength :
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Australia
Brand Name : Valproate Winthrop EC 200
Dosage Form :
Dosage Strength :
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Australia
Brand Name : Valproate Winthrop EC 500
Dosage Form :
Dosage Strength :
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
RLD : Yes
TE Code :
Brand Name : DEPAKENE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 18081
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : DEPAKENE
Dosage Form : SYRUP;ORAL
Dosage Strength : 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 18082
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code : AB
Brand Name : DEPAKOTE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 250MG VALPROIC ACID
Approval Date : 1983-03-10
Application Number : 18723
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Brand Name : DEPAKOTE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 500MG VALPROIC ACID
Approval Date : 1983-03-10
Application Number : 18723
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Brand Name : DEPAKOTE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 125MG VALPROIC ACID
Approval Date : 1984-10-26
Application Number : 18723
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Brand Name : DEPAKOTE
Dosage Form : CAPSULE, DELAYED REL PELLETS;ORAL
Dosage Strength : EQ 125MG VALPROIC ACID
Approval Date : 1989-09-12
Application Number : 19680
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Brand Name : DEPAKOTE ER
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 500MG VALPROIC ACID
Approval Date : 2000-08-04
Application Number : 21168
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Brand Name : DEPAKOTE ER
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 250MG VALPROIC ACID
Approval Date : 2002-05-31
Application Number : 21168
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD :
TE Code :
Brand Name : DEPAKOTE ER
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Dosage Strength : 250MG
Approval Date :
Application Number : 22267
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Brand Name : DEPAKOTE ER
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Dosage Strength : 500MG
Approval Date :
Application Number : 22267
RX/OTC/DISCN :
RLD :
TE Code :
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Powder
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Brand Name : EUDRAGIT® L 100-55
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Application : Solubilizers
Excipient Details : EUDRAGIT® L 12,5 (organic solution), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets and capsules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Brand Name : EUDRAGIT® L 30 D-55
Application : Film Formers & Plasticizers
Excipient Details : EUDRAGIT® L 30 D-55 (aqueous dispersion) is a delayed release polymer used as coating and film former in tablets, capsules, granules etc.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Brand Name : EUDRAGIT® RS 12,5
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® RS 12,5 (Organic solution) is a sustained release polymer for customized release profiles used in combination with EUDRAGIT® RL.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : A&C’s Acetone NF meets the USP-NF monograph.
Dosage Form : Capsule
Grade : Oral
Application : Solubilizers
Excipient Details : A & C's Maltodextrin is an excipient which meets the NF monograph.
Dosage Form : Gel
Grade : Parenteral, Topical
Brand Name : Polyethylene Glycol 200 N...
Application : Topical
Excipient Details : A & C's Polyethylene Glycol 200 is an excipient which meets the NF monograph.
Pharmacopoeia Ref : NF
Technical Specs : Polyethylene Glycol 200; Polyethylene Glycol 300; Polyethylene Glycol 400; Low Endotoxin
Ingredient(s) : polyethylene glycol
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
Brand Name : Polyethylene Glycol 300 N...
Application : Topical
Excipient Details : A & C's Polyethylene Glycol 300 is an excipient which meets the NF monograph.
Dosage Form : Gel
Grade : Topical, Parenteral
Brand Name : Polyethylene Glycol 400
Application : Topical
Excipient Details : A&C's Polyethylene Glycol 400 USP-NF is a short chain non-ionic surfactant.
Pharmacopoeia Ref : Not Available
Technical Specs : Low Endotoxin
Ingredient(s) : polyethylene glycol
Dosage Form : Tablet
Grade : Topical and Oral
Brand Name : Polyethylene Glycol 400
Application : Controlled & Modified Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : polyethylene glycol
Dosage Form : Capsule
Grade : Oral
Brand Name : Polysorbate 80 Multi-Comp...
Application : Solubilizers
Excipient Details : A & C's Polysorbate 80 multi-compendial is an excipient which meets USP-NF, EP, BP and JP monographs.
Dosage Form : Capsule
Grade : Oral
Brand Name : Polysorbate 80 NF
Application : Solubilizers
Excipient Details : A & C's Polysorbate 80 is an excipient which meets the NF monograph.
Dosage Form : Cream / Lotion / Ointment
Grade : Topical and Oral
Application : Topical
Dosage Form : Syrup
Grade : Oral
Brand Name : Sucrose Multi-Compendial
Application : Taste Masking
Excipient Details : A & C's Sucrose multi-compendial is a pharmaceutical excipient grade meeting the current specifications of USP-NF, EP and JP monographs.
Dosage Form : Tablet
Grade : Not Available
Application : Controlled & Modified Release
Excipient Details : Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying
Dosage Form : Tablet
Grade : Not Available
Application : Solubilizers
Excipient Details : Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying
Pharmacopoeia Ref : Ph. Eur., USP, JP: Povidone
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Capsule
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.
Pharmacopoeia Ref : Ph. Eur., USP, JP: Povidone
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : Maximum disintegration
Pharmacopoeia Ref : Ph. Eur., USP, JP: Crospovidon...
Technical Specs : Not Available
Ingredient(s) : Polyvinylpyrrolidone Crosslinked
Dosage Form : Capsule
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.
Pharmacopoeia Ref : Ph. Eur., USP, JP: Crospovidon...
Technical Specs : Not Available
Ingredient(s) : Polyvinylpyrrolidone Crosslinked
Dosage Form : Tablet
Grade : Not Available
Application : Granulation
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Tablet
Grade : Not Available
Application : Film Formers & Plasticizers
Excipient Details : Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Propylene Glycol
Dosage Form : Softgel Capsule
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : Structure-building consistency factor with dry feel, forms crystalline barrier on skin
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP: Stearic ...
Technical Specs : Not Available
Ingredient(s) : Stearic Acid
Dosage Form : Orodispersible Tablet
Grade : Not Available
Application : Chewable & Orodispersible Aids
Excipient Details : Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.
Pharmacopoeia Ref : Ph. Eur., USP, JP: 90 % mannit...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Tablet
Grade : Not Available
Application : Granulation
Excipient Details : Ready-to-use direct compression solution for tablets.
Pharmacopoeia Ref : Ph.Eur., USP/NF and JP
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Tablet
Grade : Topical and Oral
Brand Name : Polyethylene Glycol 400
Application : Controlled & Modified Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : polyethylene glycol
Dosage Form : Cream / Lotion / Ointment
Grade : Topical and Oral
Application : Topical
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Mannitol is used as a filler and binder in the manufacturing of oral solid dosage forms such as tablets.
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : Sodium Starch Glycolate, Potato is used as a superdisintegrant in the oral dosage forms such as tablets.
Dosage Form : Emulsion
Grade : Oral, Topical
Application : Thickeners and Stabilizers
Excipient Details : Modified Starch, Corn is a white powder and a unique emulsion stabilising starch derived from waxy maize.
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Fully Pregel Starch Corn is used as a binder in wet granulation in the manufacturing of tablets.
Pharmacopoeia Ref : USP/NF, Ph. Eur., Ch. P.
Technical Specs : NA
Ingredient(s) : Corn Starch, Pregelatinized
Excipients by Applications
Global Sales Information
Market Place
Reply
22 May 2025
Reply
03 Feb 2025
Reply
26 Sep 2024
Reply
19 Aug 2023
Reply
21 Jul 2023
Reply
02 Dec 2022
Reply
21 Nov 2022
Reply
12 Nov 2022
Reply
13 Oct 2022
Reply
06 Jul 2022
REF. STANDARDS & IMPURITIES
CAS Number : 99-66-1
Quantity Per Vial : 100 mg
Sale Unit : 1
Order Code : V0033000
Batch No : 3
Price (€) : 79
Storage : +5°C ± 3°C
Valproic acid for system suitability
CAS Number : 99-66-1
Quantity Per Vial : 10 mg
Sale Unit : 1
Order Code : Y0001422
Batch No : 3
Price (€) : 79
Storage : +5°C ± 3°C
ANALYTICAL
ABOUT THIS PAGE
77
PharmaCompass offers a list of Divalproex Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Divalproex Sodium manufacturer or Divalproex Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Divalproex Sodium manufacturer or Divalproex Sodium supplier.
PharmaCompass also assists you with knowing the Divalproex Sodium API Price utilized in the formulation of products. Divalproex Sodium API Price is not always fixed or binding as the Divalproex Sodium Price is obtained through a variety of data sources. The Divalproex Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Divalproex Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Divalproex Sodium, including repackagers and relabelers. The FDA regulates Divalproex Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Divalproex Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Divalproex Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Divalproex Sodium supplier is an individual or a company that provides Divalproex Sodium active pharmaceutical ingredient (API) or Divalproex Sodium finished formulations upon request. The Divalproex Sodium suppliers may include Divalproex Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Divalproex Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Divalproex Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Divalproex Sodium active pharmaceutical ingredient (API) in detail. Different forms of Divalproex Sodium DMFs exist exist since differing nations have different regulations, such as Divalproex Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Divalproex Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Divalproex Sodium USDMF includes data on Divalproex Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Divalproex Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Divalproex Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Divalproex Sodium Drug Master File in Japan (Divalproex Sodium JDMF) empowers Divalproex Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Divalproex Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Divalproex Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Divalproex Sodium suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Divalproex Sodium Drug Master File in Korea (Divalproex Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Divalproex Sodium. The MFDS reviews the Divalproex Sodium KDMF as part of the drug registration process and uses the information provided in the Divalproex Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Divalproex Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Divalproex Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Divalproex Sodium suppliers with KDMF on PharmaCompass.
A Divalproex Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Divalproex Sodium Certificate of Suitability (COS). The purpose of a Divalproex Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Divalproex Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Divalproex Sodium to their clients by showing that a Divalproex Sodium CEP has been issued for it. The manufacturer submits a Divalproex Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Divalproex Sodium CEP holder for the record. Additionally, the data presented in the Divalproex Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Divalproex Sodium DMF.
A Divalproex Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Divalproex Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Divalproex Sodium suppliers with CEP (COS) on PharmaCompass.
A Divalproex Sodium written confirmation (Divalproex Sodium WC) is an official document issued by a regulatory agency to a Divalproex Sodium manufacturer, verifying that the manufacturing facility of a Divalproex Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Divalproex Sodium APIs or Divalproex Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Divalproex Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Divalproex Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Divalproex Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Divalproex Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Divalproex Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Divalproex Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Divalproex Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Divalproex Sodium suppliers with NDC on PharmaCompass.
Divalproex Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Divalproex Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Divalproex Sodium GMP manufacturer or Divalproex Sodium GMP API supplier for your needs.
A Divalproex Sodium CoA (Certificate of Analysis) is a formal document that attests to Divalproex Sodium's compliance with Divalproex Sodium specifications and serves as a tool for batch-level quality control.
Divalproex Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Divalproex Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Divalproex Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Divalproex Sodium EP), Divalproex Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Divalproex Sodium USP).